Konjac Glucomannan Ameliorates Hyperlipidemia via Gut Microbiota-Bile Acid Pathway

被引：1
|
作者：
Zou X. [1 ]
Deng J. [1 ]
Zhong J. [1 ]
Wang Q. [1 ]
He F. [1 ]
Sun Y. [1 ]
Li M. [1 ]
机构：
[1] Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, Guangzhou
来源：
Shipin Kexue/Food Science | 2022年 / 43卷 / 23期
关键词：
Bile acids; Gut microbiota; Hypolipidemic effect; Konjac glucomannan;
D O I：
10.7506/spkx1002-6630-20211224-291
中图分类号：
学科分类号：
摘要：
The hypolipidemic effect and mechanism of konjac glucomannan (KGM) were investigated in hyperlipidemic hamsters from the perspective of the relationship between the gut microbiota and bile acid metabolism. Five-week-old hamsters were divided randomly into control, high fat diet (HFD), 2% (m/m) KGM, 6% KGM and 10% KGM groups. Serum and hepatic lipid levels were assessed, and the effect of KGM treatment on the gut microbiota and bile acid metabolism were analyzed after five-week administration. Our results suggested that 6% and 10% KGM treatments significantly decreased serum total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C) and hepatic TC levels. Totally 51 differential metabolites were found between the HFD versus control and KGM groups, and enrichment analysis showed that bile acids accounted for the highest proportion (24%) of the total number of metabolites. Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis showed a significant alteration in the primary bile acid synthesis pathway. Administration with 6% and 10% KGM significantly reduced the relative abundance of Bilophila and bile salt hydrolase (BSH)-related bacteria, Bifidobacterium and Lactobacillus, and decreased the levels of deoxycholic acid(DCA) and lithocholic acid (LCA) in cecal contents. Besides, the mRNA expression of cholesterol 7α-hydroxylase (CYP7A1)was unregulated in the 6% KGM group. Taken together, KGM treatment significantly decreased the relative abundance of Bilophila and BSH-related bacteria in the gut, upregulated the gene expression of CYP7A1 to regulate the levels of bile acids, thus modulating dyslipidemia. © 2022, China Food Publishing Company. All right reserved.
引用
收藏
页码：113 / 124
页数：11
相关论文
共 32 条
  • [1] TOTH P P, HULL M, GRANOWITZ C, Et al., Real-world analyses of patients with elevated atherosclerotic cardiovascular disease risk from the Optum Research Database, Future Cardiology, 17, 4, pp. 743-755, (2020)
  • [2] MOSZAK M, SZULINSKA M, BOGDANSKI P., You are what you eat: the relationship between diet, microbiota, and metabolic disorders:a review, Nutrients, 12, 4, (2020)
  • [3] HE Y J, YOU C G, CASTROVIEJO D A., The potential role of gut microbiota in the prevention and treatment of lipid metabolism disorders[J], International Journal of Endocrinology, 2020, (2020)
  • [4] MATEY-HERNANDEZ M L, WILLIAMS F M K, POTTER T, Et al., Genetic and microbiome influence on lipid metabolism and dyslipidemia, Physiological Genomics, 50, 2, pp. 117-126, (2018)
  • [5] WU T R, LIN C S, CHANG C J, Et al., Gut commensal Parabacteroides goldsteinii plays a predominant role in the antiobesity effects of polysaccharides isolated from Hirsutella sinensis, Gut, 68, 2, pp. 248-262, (2018)
  • [6] NAKAHARA D, NAN C, MORI K, Et al., Effect of mushroom polysaccharides from Pleurotus eryngii on obesity and gut microbiota in mice fed a high-fat diet, European Journal of Nutrition, 59, 7, pp. 3231-3244, (2019)
  • [7] LI L, GUO W L, ZHANG W, Et al., Grifola frondosa polysaccharides ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet fed rats, Food & Function, 10, 5, pp. 2560-2572, (2019)
  • [8] ZHENG X J, HUANG F J, ZHAO A H, Et al., Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice, BMC Biology, 15, (2017)
  • [9] JIA W, XIE G X, JIA W P., Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis, Nature Reviews Gastroenterology & Hepatology, 15, 2, pp. 111-128, (2018)
  • [10] ZALEWSKI B M, SZAJEWSKA H., Effect of glucomannan supplementation on body weight in overweight and obese children:protocol of a randomised controlled trial[J], BMJ Open, 5, 4, (2015)
1234